BCAB vs CVS · $5.9M cap vs P/E 16, rev $402.07B
Bioatla Inc (BCAB) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
BCAB currently screens at market cap $5.9M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the BCAB and CVS stock pages for the full models.
Not investment advice.